Nuvation Bio Inc. Shares Outstanding
Nuvation Bio Inc. (NUVB) had Shares Outstanding of 346.50 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-06
- 2026-06-30: Shares outstanding (split-adjusted) 346.50M shares; Shares authorized (split-adjusted) 1.06B shares.
- 2026-03-31: Shares outstanding (split-adjusted) 346.50M shares; Shares authorized (split-adjusted) 1.06B shares.
- 2025-12-31: Shares outstanding (split-adjusted) 346.50M shares; Shares authorized (split-adjusted) 1.06B shares.
- 2025-09-30: Shares outstanding (split-adjusted) 337.84M shares; Shares authorized (split-adjusted) 1.06B shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 346.50M shares 10-Q · filed 2026-08-06 | 1.06B shares 10-Q · filed 2026-08-06 |
| 2026-03-31 | 346.50M shares 10-Q · filed 2026-05-04 | 1.06B shares 10-Q · filed 2026-05-04 |
| 2025-12-31 | 346.50M shares 10-Q · filed 2026-08-06 | 1.06B shares 10-Q · filed 2026-08-06 |
| 2025-09-30 | 337.84M shares 10-Q · filed 2025-11-03 | 1.06B shares 10-Q · filed 2025-11-03 |
| 2025-06-30 | 337.84M shares 10-Q · filed 2025-08-07 | 1.06B shares 10-Q · filed 2025-08-07 |
| 2025-03-31 | 337.84M shares 10-Q · filed 2025-05-07 | 1.06B shares 10-Q · filed 2025-05-07 |
| 2024-12-31 | 337.84M shares 10-K · filed 2026-03-02 | 346.50M shares 10-K · filed 2026-03-02 |
| 2024-09-30 | 336.25M shares 10-Q · filed 2024-11-06 | (m) |
| 2024-06-30 | 248.62M shares 10-Q · filed 2024-08-05 | (m) |
| 2024-03-31 | 219.08M shares 10-Q · filed 2024-05-14 | (m) |
| 2023-12-31 | 219.05M shares 10-K · filed 2025-03-06 | (m) |
| 2023-09-30 | 218.94M shares 10-Q · filed 2023-11-02 | (m) |
| 2023-06-30 | 218.90M shares 10-Q · filed 2023-08-03 | (m) |
| 2023-03-31 | 218.80M shares 10-Q · filed 2023-05-04 | (m) |
| 2022-12-31 | 218.63M shares 10-K · filed 2024-02-29 | (m) |
| 2022-09-30 | 218.39M shares 10-Q · filed 2022-11-03 | (m) |
| 2022-06-30 | 218.24M shares 10-Q · filed 2022-08-04 | (m) |
| 2022-03-31 | 218.13M shares 10-Q · filed 2022-05-09 | 1.06B shares 10-Q · filed 2022-05-09 |
| 2021-12-31 | 217.95M shares 10-K · filed 2023-03-15 | 1.06B shares 10-Q · filed 2022-05-09 |
| 2021-09-30 | 217.78M shares 10-Q · filed 2021-11-10 | 1.06B shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 217.76M shares 10-Q · filed 2021-08-12 | 1.06B shares 10-Q · filed 2021-08-12 |
| 2021-03-31 | 217.65M shares 10-Q · filed 2021-05-17 | 1.06B shares 10-Q · filed 2021-05-17 |
| 2020-12-31 | 149.04M shares 10-K · filed 2022-02-28 | 1.17B shares 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |